State’s medicine supply deal is extended to July
The pharma sector has agreed to delay new negotiations to create certainty during the ongoing pandemic
The pharmaceutical industry has agreed another six-month extension to its medicine supply deal with the state, the Business Post has learned.
The Irish Pharmaceutical Healthcare Association (IPHA), which represents the country’s biopharmaceutical industry, reached an original extension deal with the HSE and the Department of Health back in July that ended in January.
Following the pressure on health authorities due to the third wave of Covid-19, the IPHA last week agreed...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Ireland’s medicinal cannabis scheme needs overhaul, advocate says
Prohibition Partners says patients are being done a ‘disservice’ while state is losing out on economic benefits of an industry predicted to be worth €3.2 billion by 2025
Some people with cystic fibrosis still awaiting Covid-19 vaccine, charity warns
Cystic Fibrosis Ireland expresses concern about younger patients who are at very high risk from the coronavirus but still have not received their jab
Top medic: ‘If the state can pay for Viagra, it can pay for extreme pregnancy sickness drugs’
Peter Boylan, a former master of the National Maternity Hospital, says hyperemesis gravidarum is a severe condition and it‘s reasonable to expect the drugs payment scheme to reimburse sufferers
Over 300 administered vaccine doses not recorded as given to priority groups
HSE says failure to record cohort of vaccine recipient may be due to poor record keeping or a technical issue